Gillian McGovern is an associate editor at Pharmacy Times®. She graduated from Rowan University in 2023 with a BA in Writing Arts and concentrations in Publishing & Writing for the Public, Technical & Professional Writing, and Creative Writing.
Prevalence of CKD in Patients With LN and SLE Ranges From 10% to Almost 50%, Review Finds
February 4th 2025Some risk factors for chronic kidney disease (CKD) in patients with lupus nephritis (LN) and systemic lupus erythematosus (SLE) were renal impairment, delayed diagnosis, and hypertension.
Read More
Mitochondrial Dysfunction Present in Visceral Adipose Tissue in Patients With Obesity-Related MASH
January 29th 2025The authors note that this may cause disruptions in the metabolic stability of lipid processing and storage, impacting the liver and accelerating damaging adaptative responses.
Read More
FDA Grants Approval to Generic Extended-Release Memantine/Donepezil and Everolimus
Published: January 23rd 2025 | Updated: January 23rd 2025Memantine/donepezil and everolimus are used to treat dementia of the Alzheimer type and tuberous sclerosis complex-associated subependymal giant cell astrocytoma, respectively.
Read More
Air Pollution and Seasonal Variability Associated With Asthma- and COPD-Related Hospital Admissions
January 20th 2025The authors found that humidity, cold and heat waves, and air pollution led to a higher likelihood of asthma- and chronic obstructive pulmonary disease (COPD)-related hospitalizations.
Read More
Study Shows Potential Population-Level Benefits of Intensive BP Targets in Adults With CKD
January 20th 2025The reduction in cardiovascular end points and the increase in adverse events observed in a clinical trial were largely transportable to trial-eligible chronic kidney disease (CKD) populations from clinical practice.
Read More